Dr. Reynolds is the Division Chief of Neonatology with continuous NIH sponsored research since 2009, a busy clinical practice and deep desire to teach the next generation of Pediatricians and Neonatologists. Her research interests focus on common Neonatal lung disease related to prematurity and she has participated as site PI at the University at Buffalo in two previous large multicenter studies related to ways to reduce the risk of Bronchopulmonary Dysplasia in extremely premature infants and the more recent Prematurity Respiratory Outcomes Program (PROP), which aimed to find biomarkers that may predict patients that are likely to have more severe courses during the first year of life related to their pulmonary disease. We are following patients from the PROP cohort in another large current multicenter NIH trial that focuses on late effects of Neonatal Intensive Care exposures as well.
She is also the Co-Primary Investigator for the University in the Neonatal Research Network (NRN). As part of this prestigious research group, our NICU participates in 5-10 simultaneous clinical studies that investigate novel approaches to common and sometime uncommon Neonatal diseases as well as observational studies that will help us to explore neurodevelopmental outcomes for these infants in a more robust manner.
Quality Improvement has been another important interest and she has been an active participant and subject matter expert with the NYS Department of Health Quality Initiatives to improve NICU outcomes across the state since 2011. The first project aimed to improve growth after premature birth for hospitalized patients during which time our clinical site, The Women and Children’s Hospital of Buffalo, had the lowest percentage of patients discharged below the 10th percentile in NYS.
The second NYS Department of Health Quality Initiative aimed to reduce the number of Central Line Associated Blood Stream Infections across level III NICUs and RPCs in NYS. As a result of initiatives lead by Dr. Reynolds, our NICU made a number of improvements in our process for central line insertion and maintenance including use of a procedure cart, increased monitoring of best practice and best practice checklists, a sterile tubing change and a standardized line kit designed by our team. CLABSI rate was reduced from 2.68 per 1,000 line days in 2012 to 0.25/1,000 line days in 2015.
While attending in the 64 bed level IV Regional Perinatal Center with full pediatric subspecialty support, Dr. Reynolds enjoys teaching medical students, residents and fellows and has worked with many of them on their own quality improvement projects with multiple projects winning the University at Buffalo GME Quality Improvement Award.

Neonatal-Perinatal Medicine, Neonatology, Pediatrics

Physician Gender:

Female